Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

Summary Background Angiotensin receptor blockers (ARB) and angiotensin converting enzyme (ACE) inhibitors are known to reduce proteinuria. Their combination might be more effective than either treatment alone, but long-term data for comparative changes in renal function are not available. We investi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet (British edition) 2008-08, Vol.372 (9638), p.547-553
Hauptverfasser: Mann, Johannes FE, Prof, Schmieder, Roland E, Prof, McQueen, Matthew, Prof, Dyal, Leanne, MSc, Schumacher, Helmut, MD, Pogue, Janice, PhD, Wang, Xingyu, PhD, Maggioni, Aldo, MD, Budaj, Andrzej, MD, Chaithiraphan, Suphachai, Prof, Dickstein, Kenneth, MD, Keltai, Matyas, Prof, Metsärinne, Kaj, MD, Oto, Ali, Prof, Parkhomenko, Alexander, MD, Piegas, Leopoldo S, MD, Svendsen, Tage L, MD, Teo, Koon K, Prof, Yusuf, Salim, Prof
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!